Variables | Physicians Who Measure Quantitatively, n = 255 | Physicians Who Do Not Measure Quantitatively, n = 184 | p |
---|---|---|---|
Physician characteristics and practice patterns | |||
Age, yrs, mean (SD) | 56.7 (9.8) | 57.8 (9.9) | 0.20 |
Male | 73 | 72 | 0.85 |
Practice setting, n physicians | |||
Academic | 24 | 23 | 0.005 |
Solo practice | 18 | 28 | |
Rheumatology group | 29 | 15 | |
Multispecialty group | 22 | 20 | |
Other | 11 | 10 | |
> 20 RA patients seen per week | 60 | 54 | 0.20 |
Yrs in rheumatologic practice | |||
≤ 20 | 35 | 33 | 0.54 |
21–30 | 36 | 33 | |
> 30 | 30 | 35 | |
Use TNF inhibitors for at least 50% of RA patients | 76 | 66 | 0.02 |
How many TNF inhibitors must a patient fail before you choose another MOA? | |||
Exactly 1 | 31 | 26 | 0.22 |
2 | 65 | 73 | |
3+ | 1 | 2 | |
None; non-TNF MOA biologics are my first line | 1 | 2 | |
Beliefs about treating to target and RA patient outcomes | |||
Doesn’t believe in “treat-to-target hype” | 14 | 42 | < 0.01 |
What fraction of your RA patients achieve remission? | |||
< 20 | 20 | 17 | 0.90 |
20 – < 30 | 20 | 20 | |
30 – < 50 | 24 | 24 | |
≥ 50 | 37 | 39 | |
What fraction of your RA patients achieve low disease activity? | |||
< 50 | 25 | 22 | 0.73 |
50 – < 60 | 14 | 13 | |
60 – < 80 | 32 | 35 | |
≥ 80 | 29 | 31 |
Some column totals may not sum exactly to 100% because of rounding. RA: rheumatoid arthritis; TNF: tumor necrosis factor; MOA: mechanism of action.